Table 3.
Characteristic | Luminal B (n = 70) | Non-luminal HER2-expressing (n = 38) | Triple-negative breast cancer (n = 91) |
---|---|---|---|
| |||
OR (95% CI)a | OR (95% CI)a | OR (95% CI)a | |
Sociodemographic characteristics | |||
Age at diagnosis (years) | |||
<45 | 2.1 (1.2, 3.8) | 1.9 (0.9, 4.1) | 1.7 (1.0, 2.9) |
≥45 | 1.0 (Referent) | 1.0 (Referent) | 1.0 (Referent) |
Race | |||
White | 1.0 (Referent) | 1.0 (Referent) | 1.0 (Referent) |
African American | 1.9 (1.1, 3.1) | 1.3 (0.7, 2.5) | 2.7 (1.7, 4.3) |
Marital statusb | |||
Married or living as married | 1.0 (Referent) | 1.0 (Referent) | 1.0 (Referent) |
Unmarried | 1.0 (0.6, 1.8) | 1.8 (0.9, 3.7) | 1.1 (0.6, 1.8) |
Unknown | 0.8 (0.4, 1.6) | 0.7 (0.2, 2.0) | 1.0 (0.5, 1.8) |
Education | |||
Below college | 0.7 (0.4, 1.1) | 1.1 (0.5, 2.2) | 1.6 (1.0, 2.7) |
College graduate and above | 1.0 (Referent) | 1.0 (Referent) | 1.0 (Referent) |
Unknown | 0.3 (0.1, 0.9) | 0.4 (0.1, 1.7) | 1.6 (0.8, 3.3) |
Annual household incomec | |||
<$70,000 | 1.2 (0.7, 2.3) | 1.5 (0.7, 3.2) | 1.8 (1.1, 3.2) |
≥$70,000 | 1.0 (Referent) | 1.0 (Referent) | 1.0 (Referent) |
Unknown | 1.0 (0.5, 1.9) | 0.9 (0.4, 2.2) | 1.2 (0.7, 2.3) |
Primary health insurance | |||
Non-private | 0.4 (0.2, 0.8) | 0.7 (0.3, 1.5) | 0.9 (0.5, 1.5) |
Private | 1.0 (Referent) | 1.0 (Referent) | 1.0 (Referent) |
Unknown | 1.0 (0.4, 2.7) | 0.4 (0.1, 2.9) | 1.1 (0.4, 2.7) |
Reproductive and clinical characteristics | |||
Menopausal status | |||
Pre | 1.9 (1.1, 3.1) | 1.2 (0.6, 2.5) | 1.3 (0.8, 2.1) |
Post | 1.0 (Referent) | 1.0 (Referent) | 1.0 (Referent) |
Age at menarche (years) | |||
<12 | 0.6 (0.3, 1.5) | 1.4 (0.5, 4.3) | 1.6 (0.7, 3.6) |
12 – 13 | 1.1 (0.5, 2.1) | 1.5 (0.5, 4.1) | 1.6 (0.8, 3.4) |
>13 | 1.0 (Referent) | 1.0 (Referent) | 1.0 (Referent) |
Unknown | 0.7 (0.3, 1.5) | 0.8 (0.2, 2.8) | 1.4 (0.6, 3.2) |
Parity | |||
Nulliparous | 1.0 (Referent) | 1.0 (Referent) | 1.0 (Referent) |
Parous | 1.2 (0.6, 2.4) | 1.0 (0.4, 2.4) | 1.0 (0.5, 1.9) |
Unknown | 0.8 (0.3, 1.8) | 0.6 (0.2, 1.9) | 1.0 (0.5, 2.0) |
Parityd | |||
1 – 2 children | 1.0 (Referent) | 1.0 (Referent) | 1.0 (Referent) |
≥3 children | 0.9 (0.4, 1.6) | 0.9 (0.4, 2.2) | 1.0 (0.6, 1.9) |
History of breastfeedingd | |||
No | 1.0 (Referent) | 1.0 (Referent) | 1.0 (Referent) |
Yes | 1.1 (0.6, 2.1) | 1.2 (0.5, 2.6) | 0.7 (0.4, 1.3) |
History of oral contraceptive use | |||
Never | 1.0 (Referent) | 1.0 (Referent) | 1.0 (Referent) |
Ever | 1.1 (0.6, 2.0) | 1.0 (0.5, 2.2) | 1.3 (0.8, 2.4) |
Unknown | 0.7 (0.3, 1.6) | 0.6 (0.2, 1.7) | 1.2 (0.6, 2.3) |
History of HRT use | |||
Never | 1.0 (Referent) | 1.0 (Referent) | 1.0 (Referent) |
Ever | 0.7 (0.3, 1.5) | 1.1 (0.4, 2.6) | 1.1 (0.6, 2.1) |
Unknown | 0.6 (0.3, 1.2) | 0.6 (0.2, 1.5) | 1.0 (0.6, 1.7) |
Family history of breast cancer | |||
No | 1.0 (Referent) | 1.0 (Referent) | 1.0 (Referent) |
Yes | 1.0 (0.6, 1.6) | 0.6 (0.3, 1.3) | 0.8 (0.5, 1.3) |
BMI (kg/m2) | |||
<25.0 | 1.0 (Referent) | 1.0 (Referent) | 1.0 (Referent) |
25.0 – 29.99 | 0.9 (0.5, 1.7) | 1.0 (0.5, 2.3) | 1.7 (0.9, 3.1) |
≥30.0 | 0.9 (0.5, 1.6) | 0.6 (0.3, 1.3) | 1.4 (0.8, 2.4) |
Unknown | |||
Comorbid conditions | |||
0 | 1.0 (Referent) | 1.0 (Referent) | 1.0 (Referent) |
≥1 | 0.6 (0.3, 1.0) | 0.8 (0.4, 1.6) | 1.1 (0.6, 2.0) |
Diabetes | |||
Yes | 1.4 (0.7, 2.7) | 1.9 (0.8, 4.5) | 1.1 (0.6, 2.2) |
No | 1.0 (Referent) | 1.0 (Referent) | 1.0 (Referent) |
Hypertension | |||
Yes | 1.0 (0.6, 1.6) | 0.8 (0.4, 1.6) | 1.4 (0.9, 2.2) |
No | 1.0 (Referent) | 1.0 (Referent) | 1.0 (Referent) |
Osteoporosis/osteopenia | |||
Yes | 0.6 (0.3, 1.1) | 0.5 (0.2, 1.2) | 0.6 (0.4, 1.1) |
No | 1.0 (Referent) | 1.0 (Referent) | 1.0 (Referent) |
Arthritis | |||
Yes | 0.8 (0.5, 1.6) | 1.1 (0.5, 2.4) | 0.6 (0.3, 1.1) |
No | 1.0 (Referent) | 1.0 (Referent) | 1.0 (Referent) |
Tumor characteristics | |||
Mode of detection | |||
Patient self-detecting | 1.8 (1.1, 3.1) | 2.4 (1.2, 4.7) | 2.7 (1.7, 4.2) |
Patient not self-detecting | 1.0 (Referent) | 1.0 (Referent) | 1.0 (Referent) |
History of benign breast disease | |||
No | 1.0 (Referent) | 1.0 (Referent) | 1.0 (Referent) |
Yes | 0.8 (0.5, 1.3) | 1.1 (0.6, 2.2) | 0.6 (0.4, 1.0) |
Tumor grade | |||
Well/moderately differentiated | 1.0 (Referent) | 1.0 (Referent) | 1.0 (Referent) |
Poorly differentiated | 3.3 (1.9, 5.6) | 16.7 (6.7, 41.5) | 13.8 (7.9, 24.4) |
Unknown | -- | -- | -- |
AJCC stage | |||
Stage I | 1.0 (Referent) | 1.0 (Referent) | 1.0 (Referent) |
Stage II and above | 1.9 (1.1, 3.2) | 2.6 (1.3, 5.2) | 1.8 (1.2, 2.9) |
Unknown | -- | -- | -- |
Tumor size (cm) | |||
≤1.0 | 1.0 (Referent) | 1.0 (Referent) | 1.0 (Referent) |
>1.0 | 2.0 (1.1, 3.5) | 2.5 (1.1, 5.7) | 3.4 (1.9, 6.2) |
Lymph node status | |||
Negative | 1.0 (Referent) | 1.0 (Referent) | 1.0 (Referent) |
Positive | 1.3 (0.8, 2.3) | 1.1 (0.5, 2.3) | 1.2 (0.7, 2.0) |
Unknown | -- | -- | -- |
Lymphovascular invasion present | |||
No | 1.0 (Referent) | 1.0 (Referent) | 1.0 (Referent) |
Yes | 1.9 (1.1, 3.4) | 0.9 (0.4, 2.4) | 1.2 (0.7, 2.1) |
Unknown | 0.9 (0.3, 2.1) | 1.7 (0.7, 4.2) | 1.3 (0.7, 2.6) |
p53 status positive | |||
No | 1.0 (Referent) | 1.0 (Referent) | 1.0 (Referent) |
Yes | 2.1 (0.7, 6.1) | 3.3 (1.0, 10.4) | 5.0 (2.3, 10.8) |
Ki67 status positive | |||
No | 1.0 (Referent) | 1.0 (Referent) | 1.0 (Referent) |
Yes | 2.6 (1.5, 4.5) | 2.7 (1.3, 5.5) | 4.2 (2.6, 6.7) |
Abbreviations: HER2, human epidermal growth factor receptor 2; OR, odds ratio; CI, confidence interval; BMI, body mass index; HRT, Hormone Replacement Therapy; AJCC, American Joint Committee on Cancer.
ORs and 95% CIs were generated from univariate multinomial logistic regression models with the luminal A subtype as the referent group.
The unmarried group was composed of those who were single/never been married, separated, divorced, or widowed.
$70,000 is the median income among households in New Jersey and thus was used as the cut-point to dichotomize the income variable.
Number of children and history of breastfeeding were among parous women only (N = 385).